4. References

  1. IBM Micromedex® DRUGDEX® (electronic version). IBM Watson Health, Greenwood Village, Colorado, USA. Available at: https://www-micromedexsolutions-com.libproxy.uthscsa.edu/ (cited: March 9, 2022).
  2. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed March 9, 2022.
  3. Berotralstat oral capsules (Orladeyo®) package insert. BioCryst Pharmaceuticals, Inc., December 2020.
  4. C1 esterase inhibitor, human (Berinert®) package insert. CSL Behring, September 2021.
  5. C1 esterase inhibitor, human intravenous injection (Cinryze®) package insert. ViroPharma Biologics LLC, January 2021.
  6. C1 esterase inhibitor subcutaneous injection (Haegarda®) package insert. CSL Behring, October 2020.
  7. C1 esterase inhibitor, recombinant (Ruconest®) package insert.  Pharming Healthcare Inc., April 2020.
  8. Ecallantide subcutaneous injection (Kalbitor®) package insert. Takeda Pharmaceuticals America, Inc., November 2021.
  9. Eculizumab intravenous injection (Soliris®) package insert. Alexion Pharmaceuticals, Inc., April 2021.
  10. Icatibant subcutaneous injection (Firazyr®) package insert. Takeda Pharmaceuticals America, Inc., September 2020.
  11. Icatibant subcutaneous injection (Sajazir®) package insert. Cycle Pharmaceuticals LTD., June 2021.
  12. Lanadelumab subcutaneous injection (Takhzyro®) package insert. Takeda Pharmaceuticals America, Inc., February 2022.
  13. Pegcetacoplan subcutaneous solution (Empaveli®) package insert. Apellis Pharmaceuticals, Inc., August 2021.
  14. Ravulizumab intravenous injection (Ultomiris®) package insert. Alexion Pharmaceuticals, Inc., January 2022.
  15. Agalsidase beta injection (Fabrazyme®) package insert. Genzyme Corporation, August 2021.
  16. Alglucosidase alfa injection (Lumizyme®) package insert. Genzyme Corporation, July 2021.
  17. Avalglucosidase alfa intravenous injection (Nexviazyme®) package insert. Genzyme Corporation, August 2021.
  18. Elapegademase intramuscular injection (Revcovi®) package insert. Leadiant Biosciences, November 2021.
  19. Elosulfase injection (Vimizim®) package insert. BioMarin Pharmaceutical Inc., January 2021.
  20. Galsulfase injection (Naglazyme®) package insert. BioMarin Pharmaceutical Inc., April 2020.
  21. Idursulfase injection (Elaprase®) package insert. Shire Human Genetic Therapies, Inc., October 2021.
  22. Imiglucerase injection (Cerezyme®) package insert. Genzyme Corporation, January 2022.
  23. Laronidase intravenous infusion (Aldurazyme®) package insert.  Genzyme Corporation, December 2019.
  24. Migalastat oral capsules (Galafold®) package insert. Amicus Therapeutics US, LLC, December 2021.
  25. Sacrosidase oral solution (Sucraid®) package insert. QOL Medical, LLC, August 2021.
  26. Sebelipase injection (Kanuma®) package insert. Alexion Pharmaceuticals, Inc., November 2021. 
  27. Taliglucerase alfa injection (Elelyso®) package insert. Pfizer, July 2021.
  28. Velaglucerase alfa injection (Vpriv®) package insert. Takeda Pharmaceuticals America, Inc., October 2021.
  29. Vestronidase alfa-vjbk injection (Mepsevii®) package insert. Ultragenyx Pharmaceutical Inc., December 2020.
  30. Protein C concentrate (Ceprotin®) package insert. Baxalta US Inc., September 2021.
  31. Asfotase alfa injection (Strensiq®) package insert. Alexion Pharmaceuticals, Inc., April 2021.
  32. Cerliponase alfa injection (Brineura®) package insert. BioMarin Pharmaceutical Inc., July 2020.
  33. Ramaswami U, Parini R, Kampmann C, Beck M. Safety of agalsidase alfa in patients with Fabry disease under 7 years. Acta Paediatrica. 2011;100(4):605-11.